Clinical features and outcome of the patients with sinonasal tract diffuse large B‐cell lymphoma in the pre‐rituximab and rituximab eras.

MLA

Mannisto, Susanna, et al. “Clinical Features and Outcome of the Patients with Sinonasal Tract Diffuse Large B‐cell Lymphoma in the Pre‐rituximab and Rituximab Eras.” European Journal of Haematology, vol. 102, no. 6, June 2019, pp. 457–64. EBSCOhost, https://doi.org/10.1111/ejh.13225.

APA

Mannisto, S., Leppä, S., Vähämurto, P., Pollari, M., Mäkitie, A. A., & Karjalainen, L. M. (2019). Clinical features and outcome of the patients with sinonasal tract diffuse large B‐cell lymphoma in the pre‐rituximab and rituximab eras. European Journal of Haematology, 102(6), 457–464. https://doi.org/10.1111/ejh.13225

Chicago

Mannisto, Susanna, Sirpa Leppä, Pauli Vähämurto, Marjukka Pollari, Antti A. Mäkitie, and Lindsberg, Marja‐Liisa Karjalainen. 2019. “Clinical Features and Outcome of the Patients with Sinonasal Tract Diffuse Large B‐cell Lymphoma in the Pre‐rituximab and Rituximab Eras.” European Journal of Haematology 102 (6): 457–64. doi:10.1111/ejh.13225.